This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bausch + Lomb Ireland Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Patrick McCormick and His Patent on Benzalkonium Chloride
Introduction
Patrick McCormick is an inventor associated with Rochester, New York. His patent work concerns potential uses of benzalkonium chloride in treating conjunctivitis and COVID-19.
Latest Patents
The provided information lists one patent for McCormick: “Benzalkonium chloride for use in treating conjunctivitis and/or COVID-19.” The patent describes methods for treating COVID-19, including ocular manifestations, and conjunctivitis, as well as reducing COVID-19 transmission by administering an effective amount of benzalkonium chloride. It also describes pharmaceutical compositions containing benzalkonium chloride. The listed patent count is 1 patent.
Career Highlights
McCormick is associated with Bausch + Lomb Ireland Limited. The patent reflects research into the potential role of benzalkonium chloride in addressing eye-related conditions and COVID-19.
Collaborations
The provided information identifies Kimberly Millard as McCormick’s coworker. No further details about their collaboration are available.
Conclusion
Patrick McCormick’s listed patent focuses on benzalkonium chloride formulations and methods related to conjunctivitis and COVID-19, connecting his inventive work with Bausch + Lomb Ireland Limited.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile